Editorial

View All
Your Trusted Source for Biopharma News
Editorial Resilience Is the New Biopharma Blockbuster

The biopharmaceutical sector is entering a new era. After last year's market disruptions, the industry faces a harsh truth: scientific breakthroughs alone are no longer enough to keep ahead of the…

How Tissue Engineering Is Redefining R&D and Regenerative Care
EditorialHow Tissue Engineering Is Redefining R&D and Regenerative Care

By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a

BridgeBio's Breakthrough in Limb-Girdle Muscular Dystrophy Trials
EditorialBridgeBio's Breakthrough in Limb-Girdle Muscular Dystrophy Trials

The landscape of rare disease drug development is littered with clinical failures. For every

Price Pressures Are Here: How to Plan, Launch & LCM in the IRA Era
EditorialPrice Pressures Are Here: How to Plan, Launch & LCM in the IRA Era

Major policy changes are colliding with the complex economics of drug development. For B2B

Building Resilience in Biopharma Amid Global Disruptions
EditorialBuilding Resilience in Biopharma Amid Global Disruptions

Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Can Europe Deliver on Its Promise to Beat Cancer?
Tech & Innovation Can Europe Deliver on Its Promise to Beat Cancer?

The staggering reality of cancer in Europe continues to cast a long shadow, with over 3.2 million new diagnoses and 1.5 million lives lost each year, underscoring the urgent need for a unified and effective response. Amid this challenge, a powerful new paradigm in oncology has emerged, encapsulated

Is Photon-Counting CT the Future of Lung Cancer Imaging?
Tech & InnovationIs Photon-Counting CT the Future of Lung Cancer Imaging?

The relentless pursuit of earlier and more precise lung cancer detection has continually driven

Conflicting Breakpoints Distort Global Resistance Data
Tech & InnovationConflicting Breakpoints Distort Global Resistance Data

A bacterial infection that is considered treatable in a New York hospital could be diagnosed as

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later